ResMed | RMD - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Ansell USD 274.8M 7.6M 2025-12
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Baxter International USD 728M 33M 2026-03
Cochlear AUD 449.4M 214.45M 2025-12
Cooper Companies USD 676.2M 303.1M 2026-03
CSL USD 1.23B 498M 2025-12
Dexcom USD 349.7M 49.8M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Fisher Paykel Healthcare NZD 285.5M 11.6M 2025-12
Globus Medical USD 297.77M 20.7M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
Idexx Laboratories USD 299.85M 24.18M 2026-03
Inogen USD 43.77M 510K 2024-06
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
Masimo USD 143.4M 15.4M 2026-03
Medtronic 2.96B 9M 2025-12
Philips EUR 1.18B 121M 2026-03
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 279.8M 1.4M 2026-03
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Steris USD 351.8M 500K 2026-03
Teleflex USD 226.01M 3.64M 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03